Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 5/20 | 0.45 |
| ▸ | UTS2R | Q9UKP6 | 2/20 | 0.45 |
| ▸ | PPARG | P37231 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | CES1 | P23141 | 2/20 | 0.42 |
| ▸ | SLC6A9 | P48067 | 3/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.40 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4386993 | 0.81 | SIGMAR1 (0.46) | — | |
| SCHEMBL14547167 | 0.81 | SIGMAR1 (0.46) | — | |
| SCHEMBL14028741 | 0.80 | ESR1 (0.48) | — | |
| SCHEMBL27654897 | 0.78 | CES2 (0.50) | FFAR1UTS2RCES2CES1AKR1C3 | |
| SCHEMBL24397900 | 0.78 | FFAR1 (0.41) | FFAR1UTS2RPPARGSLC6A9NPSR1 | |
| SCHEMBL2294116 | 0.78 | PABPC1 (0.55) | — | |
| SCHEMBL9608808 | 0.78 | PABPC1 (0.55) | — | |
| SCHEMBL664962 | 0.78 | PABPC1 (0.55) | — | |
| SCHEMBL11837075 | 0.77 | PABPC1 (0.37) | — | |
| SCHEMBL4242567 | 0.77 | LMNA (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102442974-B | Camphor derivative compound, and production method and use thereof | WANG BINGJUN | 2014-07-23 | — | — | CN | disclosed |
| US-8609839-B2 | Camphor-derived compounds, method for manufacturing the same, and application thereof | NATIONAL TSING HUA UNIVERSITY (TW) | 2013-12-17 | — | — | US | disclosed |
| CN-102442974-A | Camphor derivative compound, and production method and use thereof | BINGJUN WANG | 2012-05-09 | — | — | CN | disclosed |
| US-20120077976-A1 | CAMPHOR-DERIVED COMPOUNDS, METHOD FOR MANUFACTURING THE SAME, AND APPLICATION THEREOF | NATIONAL TSING HUA UNIVERSITY (TW) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120077976-A1 | CAMPHOR-DERIVED COMPOUNDS, METHOD FOR MANUFACTURING THE SAME, AND APPLICATION THEREOF | PDE10A, PDE6H, PRKAR2A | FFAR1 633/4885UTS2R 752/4885PPARG 2355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.